YTHDC2 and lung cancer: In our previous study it was demonstrated that YTH domain-containing 2 (YTHDC2), an m6A ‘reader’, was reduced in lung cancer and contributed to cell proliferation, migration and the epithelial-mesenchymal transition (EMT) process.